Will Pressure on Drug Prices Affect Clinical Trail Companies?
April 11, 2017
Will government pressure on drug prices cause drug companies to cut back on outsourcing projects to companies like ICON (ICLN)? It’s possible.
Research Reports
ICON Helps Drug Companies Do Research
December 14, 2016
ICON (ICLR) helps assist drug companies do research — and get drugs approved faster. And with Healthcare stocks down, ICLR looks like a value.
Boring ICON Helps Healthcare Companies Do Work
September 29, 2016
ICON (ICLR) is a workload outsourcer for the drug, biotech, and medical device industries. ICLR stock is boring, but has grown 16% a year the past decade.
ICON Tells the Drug Companies I Can
June 30, 2016
ICON (ICLR) helps drug and biotech drug companies perform clinical trials and drug development — and profits from doing so.
A Hillary Victory in Could Hurt Drug Stocks and ICON
March 15, 2016
Hillary Clinton wants to cut drug costs, and if she wins the Presidency this could push drug companies to cut back on R&D spending and hurt ICON.
ICON is a Value
January 19, 2016
ICON (ICLR) helps drug companies with research and will be added to the Growth Portfolio and Aggressive Growth Portfolio today.
Could Be Headwinds Ahead
November 4, 2015
ICON (ICLR) helps drug companies do research. But with legislators looking to cut back drug prices, ICLR could get cut back too.